MDD: Clinical Trials

4 trials for MDD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Recruiting 1, Terminated 1

Follow MDD: new trials by email Literature Review of MDD trials Research Report on MDD

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Statins Among Major Depressive Disorder
Rosuvastatin 10 mg tablet., Sertraline Pill - Major Depressive Disorder, MDD
Phase 3RecruitingAin Shams University1452022-10-012026-11-04
Combined Treatment of Prolonged Exposure and Pramipexole for Posttraumatic Stress Disorder and Depression
PE/Pramipexole - PTSD, MDD
Phase 3TerminatedResearch Foundation for Mental Hygiene, Inc.12019-02-192019-11-26
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment
Brexpiprazole - MDD
Phase 3CompletedOtsuka Pharmaceutical Development & Commercialization, Inc.482013-11-012016-03-29
A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
TC-5214, Placebo - Major Depressive Disorder, MDD
Phase 3CompletedAstraZeneca8132010-06-012014-04-11

Narrower conditions

Depressive Disorder, Major (3)  ·  Anxiety Disorders (1)  ·  Depression (1)  ·  Mental Disorders (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)  ·  Stress Disorders, Post-Traumatic (1)

Broader conditions

Depressive Disorder (3)  ·  Mental Disorders (3)  ·  Mood Disorders (3)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Stress Disorders, Traumatic (1)  ·  Trauma and Stressor Related Disorders (1)

Interventions

Rosuvastatin Calcium (1)  ·  Sertraline (1)  ·  Tablets (1)  ·  brexpiprazole (1)

Sponsors

Ain Shams University (1)  ·  AstraZeneca (1)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (1)  ·  Research Foundation for Mental Hygiene, Inc. (1)

Countries

United States (3)  ·  Egypt (1)  ·  Puerto Rico (1)

Top investigators

Andrew . J Cutler, MD (1)  ·  Hans A. Eriksson, MD, Ph.D, MBA (1)  ·  Junichi Hashimoto, PhD (1)  ·  Yuval Neria, PhD (1)

Results publications

PMID 25514064, PMID 34894307